![](/img/cover-not-exists.png)
A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: A GOG study
Alvarez, R.D., Sill, M., Davidson, S.A., Muller, C., Bender, D.P., DeBernardo, R., Behbakht, K., Huh, W.K.Volume:
133
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2014.03.117
Date:
June, 2014
File:
PDF, 94 KB
english, 2014